The vote was 89-3 on the motion to end debate on the Food and Drug Administration Safety and Innovation ACt (S. 3187).

A week earlier the House approved the bill and sent the amended version back to the Senate.

The legislation reauthorizes certain FDA programs and expands a user-fee program in order to speed up the FDA's approval process for certain drug and medical device applications.

Sens. Richard BurrRichard BurrSenate committee to question Kushner over Russian meetings: report Devin Nunes has jeopardized the oversight role of Congress Schumer: Trump must apologize for wiretapping claim MORE (R-N.C.), Rand PaulRand PaulTrump: 'No doubt' we'll make a deal on healthcare Overnight Defense: General says US strike probably led to civilian deaths | Tillerson to push NATO on spending | Trump taps F-35 chief Senate backs Montenegro's NATO membership MORE (R-Ky.) and Bernie SandersBernie SandersIn California race, social justice wing of Democrats finally comes of age Sanders to headline progressive 'People's Summit' The Hill's 12:30 Report MORE (I-Vt.) voted against the motion to end debate.